NCT03972527 2024-08-21
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
MuReva Phototherapy Inc.
Phase NA Completed
MuReva Phototherapy Inc.
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.